Zobrazeno 1 - 10
of 91
pro vyhledávání: '"T. Christopher Mast"'
Autor:
Deanna D. Hill, Jennifer R. Kramer, Kassie R. Chaffin, T. Christopher Mast, Michael N. Robertson, Fasiha Kanwal, Barbara A. Haber
Publikováno v:
Annals of Hepatology, Vol 28, Iss 2, Pp 100899- (2023)
Introduction and Objectives: In clinical trials, patients with hepatitis C virus (HCV) genotype (GT)1a infection and baseline resistance-associated substitutions (RASs) at amino acid positions 28, 30, 31, or 93 receiving elbasvir/grazoprevir for 12 w
Externí odkaz:
https://doaj.org/article/ceeef4e9768340788243f7e373fb10ec
Autor:
T. Christopher Mast, David Heyman, Erik Dasbach, Craig Roberts, Michelle G. Goveia, Lyn Finelli
Publikováno v:
Vaccine: X, Vol 7, Iss , Pp 100084- (2021)
Background: Infectious diseases continue to cause significant impact on human health. Vaccines are instrumental in preventing infectious diseases and mitigating pandemics and epidemics. SARS-CoV-2 is the most recent example of an urgent pandemic that
Externí odkaz:
https://doaj.org/article/ef7a4a5368e149009e3637b3252d9f5c
Autor:
Wendy P. Bannister, T. Christopher Mast, Stéphane de Wit, Jan Gerstoft, Lothar Wiese, Ana Milinkovic, Vesna Hadziosmanovic, Amanda Clarke, Line D. Rasmussen, Karine Lacombe, Philipp Schommers, Thérèse Staub, Alexandra Zagalo, Joseba J. Portu, Luba Tau, Alexandra Calmy, Matthias Cavassini, Martin Gisinger, Elena Borodulina, Amanda Mocroft, Joanne Reekie, Lars Peters
Publikováno v:
AIDS. 36:2107-2119
Weight gain is becoming increasingly prevalent amongst people with HIV (PWH) receiving contemporary antiretroviral treatment. We investigated BMI changes and clinical impact in a large prospective observational study.PWH aged ≥18 years were include
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michelle G. Goveia, Lyn Finelli, T. Christopher Mast, David Heyman, Craig S. Roberts, Erik J. Dasbach
Publikováno v:
Vaccine: X
Vaccine: X, Vol 7, Iss, Pp 100084-(2021)
Vaccine: X, Vol 7, Iss, Pp 100084-(2021)
Highlights • Vaccine preventable diseases continue to impact human health. • Web-based geographic temporal visualizations of large datasets were developed. • Data on rotavirus vaccination uptake and related medical visits was used as an example
Autor:
Brian D. Williamson, Joshua T. Schiffer, Morgan A. Marks, Chiara Wychera, Michael Boeckh, Peter B. Gilbert, Elizabeth R. Duke, Hong Wan, Bhavesh Borate, Jonathan L. Golob, Terry Stevens-Ayers, Lawrence Corey, Mary E.D. Flowers, Nicole Cossrow, Keith R. Jerome, T. Christopher Mast, Meei-Li Huang
Publikováno v:
J Clin Invest
BACKGROUND: Viral load (VL) surrogate endpoints transformed development of HIV and hepatitis C therapeutics. Surrogate endpoints for CMV-related morbidity and mortality could advance development of antiviral treatments. Although observational data su
Autor:
Keith R. Jerome, Brian D. Williamson, Peter B. Gilbert, Joshua T. Schiffer, Morgan A. Marks, Chiara Wychera, Hong Wan, Meei-Li Huang, Nicole Cossrow, Michael Boeckh, Lawrence Corey, T. Christopher Mast, Elizabeth R. Duke
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S327-S328
Introduction The paradigm for preventing clinically significant cytomegalovirus (CMV) infection and CMV disease after hematopoietic cell transplantation (HCT) has shifted from preemptive treatment to antiviral prophylaxis with the approval of letermo
Autor:
Casey Raudenbush, George J. Hanna, Yun-Ping Zhou, Hala Shamsuddin, Ronald W Leong, Walter L. Straus, T. Christopher Mast, Wayne Greaves, Brittany L Sciba
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Objective: To evaluate the risk of neural tube defects (NTDs) after exposure to raltegravir during pregnancy. Methods: Exposures to raltegravir during pregnancy reported cumulatively through May 31, 2018, to the company safety database were reviewed
Publikováno v:
Pediatric Infectious Disease Journal. 34:615-620
Background Rotavirus (RV) is the leading cause of severe acute gastroenteritis among young children. Since the US licensure of the pentavalent RV vaccine (RV5) and the monovalent RV vaccine (RV1), a decline of RV activity has been observed. Objective
Autor:
Erik R. Dubberke, Vincent X. Liu, T. Christopher Mast, John D. Greene, Vinay Mehta, Swati B. Gupta, Gabriel J. Escobar, Patricia Kipnis, Jennifer M. Baker, Nicole Cossrow
BACKGROUNDPredicting recurrentClostridium difficileinfection (rCDI) remains difficult. METHODS. We employed a retrospective cohort design. Granular electronic medical record (EMR) data had been collected from patients hospitalized at 21 Kaiser Perman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73c3260368ca7d26c2389421fcdda131
https://europepmc.org/articles/PMC6008100/
https://europepmc.org/articles/PMC6008100/